Ying Su
Ying Su publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Gastroenterology, on topics such as Gastrointestinal Tumor Research and Treatment, Ferroptosis and cancer prognosis and Gastrointestinal disorders and treatments.
- World rank
- #1,690,625 of 7,710,434 ranked researchers
- Rank in United States
- #523,061 of 1,627,098
- Works
- 35
- Citations
- 1k
- Citations per work
- 29.9
What does Ying Su research?
Ying Su's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (27%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1438.8%
- Medicine1438.8%
- Life Sciences1131.8%
- Everything else1029.4%
- 1Molecular Biology27% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Gastroenterology13% of their works
- 4Surgery6% of their works
- 5Oncology5% of their works
- 6Immunology5% of their works
Research topics
- Gastrointestinal Tumor Research and Treatment
- Ferroptosis and cancer prognosis
- Gastrointestinal disorders and treatments
- Epigenetics and DNA Methylation
- Viral Infections and Immunology Research
- Gastrointestinal Bleeding Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- RNA and protein synthesis mechanisms
Which keywords describe Ying Su's research?
The keywords of their largest research topics: Prognostic Factors, Imatinib Mesylate, Sunitinib, Epidemiology, Cancer, Ferroptosis, Intussusception and Meckel's Diverticulum.
- Translation
- Viral Infection
- Soft Tissue Sarcoma
- Myocarditis
- DNA Methylation
- Meckel's Diverticulum
- Ferroptosis
- Epidemiology
- Imatinib Mesylate
- Prognostic Factors
- Sunitinib
- Cancer
- Intussusception
- Capsule Endoscopy
- Histone Modification
- Osteosarcoma
- Upper Gastrointestinal Bleeding
- Ribosome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors112 topics
- Imatinib Mesylate81 topic
- Sunitinib81 topic
- Epidemiology72 topics
- Cancer41 topic
- Ferroptosis41 topic
- Intussusception41 topic
- Meckel's Diverticulum41 topic
- Capsule Endoscopy31 topic
- DNA Methylation31 topic
- Histone Modification31 topic
- Myocarditis31 topic
- Osteosarcoma31 topic
- Soft Tissue Sarcoma31 topic
- Upper Gastrointestinal Bleeding31 topic
- Viral Infection31 topic
- Ribosome21 topic
- Translation21 topic
Where does Ying Su work?
Ying Su's main affiliation in the publication record is Deciphera Pharmaceuticals (United States), United States.
How many publications and citations does Ying Su have?
OpenAlex counts 35 works and 1,047 citations for Ying Su, an h-index of 10, ranking #1,690,625 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Ying Su
- ying-su-hubei-university-of-technology
- ying-su-sanford-burnham-prebys-medical-discovery-institute
- ying-su-ocean-university-of-china
- ying-su-fujian-provincial-cancer-hospital
- ying-su-hubei-university-of-technology-china
- ying-su-dana-farber-cancer-institute
- ying-su-university-of-illinois-chicago
- ying-su-guangdong-ocean-university
- ying-su-national-cheng-kung-university
- ying-su-beijing-normal-university
- ying-su-harbin-medical-university
- ying-su-china-agricultural-university
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ying Su. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.